Project:
This was an academic assignment to re-design the corporate identity for Australian Custom Pharmaceuticals, Australia's largest compounding-only pharmacy. Undertaken as a major project, part of Master of Design from UTS by Alexander Vlassov. Working with a small team of designers, a professor, art director and company executives, below are the results after approximately 6 months of work. The brand is now getting implemented throughout the company and it's numerous marketing collateral.
Here is a short spill about the company and the industry itself, taken from parts of the brief.
Industry — pharmaceuticals.
Compounding is the creation of a particular pharmaceutical product to fit the unique needs of a patient. This may be done for various reasons, eg. alter the flavour of a particular medication; for patients with various allergies; for those who prefer liquid to solid medication or vice versa; to reduce or increase a dose of a particular ingredient in the medicine; and many others.
Compounding is the creation of a particular pharmaceutical product to fit the unique needs of a patient. This may be done for various reasons, eg. alter the flavour of a particular medication; for patients with various allergies; for those who prefer liquid to solid medication or vice versa; to reduce or increase a dose of a particular ingredient in the medicine; and many others.
In the past, compounding was the only way to obtain medicine, until the advent of pharmaceutical mass-manufacture which paved the way for the current medicine model, resulting in the almost $650b industry today. These days, custom compounding only serves a niche market, but is seen as a growing industry, with numerous smaller compounding pharmacies opening up around Australia. In some countries, such as Brazil, compounded medication is still the main channel of obtaining prescription medicine.
ACPHARM is taking the traditional method and using the latest equipment, formulations, pharmacological theory and computer systems to create medicine, human-error free, but still customised for an individual. It’s comparable to the big pharma quality and technique, but individualising each medicine for specific patients.
For the last 5 years there has been a general acceptance that the move back to customised medicine is inevitable — a trend that is recognized even by Big Pharma, who are investing in methods for creating bespoke medicine. There is a large push toward the use of Pharmacogenomics to alter the existing “one-size-fits-all” pharmaceutical model.
Looking at the patient’s genetics can tell a practitioner how they will react to certain medicines, and which doses the patient should be taking, allowing for custom medicine companies such as ACPHARM to create these specific medicines.
The final project show
————————————————————————————————
————————————————————————————————
Work in progress
——————————————————————————————–––———
——————————————————————————————–––———